These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19455184)

  • 21. Genetic analysis of three Korean patients with clinical features of Ehlers-Danlos syndrome type IV.
    Yang JH; Lee ST; Kim JA; Kim SH; Jang SY; Ki CS; Kim DK
    J Korean Med Sci; 2007 Aug; 22(4):698-705. PubMed ID: 17728513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II promotes thoracic aortic dissections and ruptures in Col3a1 haploinsufficient mice.
    Faugeroux J; Nematalla H; Li W; Clement M; Robidel E; Frank M; Curis E; Ait-Oufella H; Caligiuri G; Nicoletti A; Hagege A; Messas E; Bruneval P; Jeunemaitre X; Bergaya S
    Hypertension; 2013 Jul; 62(1):203-8. PubMed ID: 23630948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular type of Ehlers-Danlos syndrome.
    Watanabe A; Shimada T
    J Nippon Med Sch; 2008 Oct; 75(5):254-61. PubMed ID: 19023163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV).
    Pepin MG; Schwarze U; Rice KM; Liu M; Leistritz D; Byers PH
    Genet Med; 2014 Dec; 16(12):881-8. PubMed ID: 24922459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan.
    Watanabe A; Kosho T; Wada T; Sakai N; Fujimoto M; Fukushima Y; Shimada T
    Circ J; 2007 Feb; 71(2):261-5. PubMed ID: 17251678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen.
    Tsipouras P; Byers PH; Schwartz RC; Chu ML; Weil D; Pepe G; Cassidy SB; Ramirez F
    Hum Genet; 1986 Sep; 74(1):41-6. PubMed ID: 2875936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early venous manifestation of Ehlers-Danlos syndrome Type IV through a novel mutation in COL3A1.
    Wendorff H; Pelisek J; Zimmermann A; Mayer K; Seidel H; Weirich G; Hausser I; Siegel C; Zernecke A; Eckstein HH
    Cardiovasc Pathol; 2013; 22(6):488-92. PubMed ID: 23688910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of de novo variants and parental mosaicism in vascular Ehlers-Danlos syndrome.
    Legrand A; Devriese M; Dupuis-Girod S; Simian C; Venisse A; Mazzella JM; Auribault K; Adham S; Frank M; Albuisson J; Jeunemaitre X
    Genet Med; 2019 Jul; 21(7):1568-1575. PubMed ID: 30474650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ehlers-Danlos syndrome type IV with few extrathoracic findings: a newly recognized point mutation in the COL3A1 gene.
    Watanabe A; Kawabata Y; Okada O; Tanabe N; Kimura H; Hatamochi A; Shinkai H; Sakai N; Shimada T; Hiroshima K; Kuriyama T
    Eur Respir J; 2002 Jan; 19(1):195-8. PubMed ID: 11843319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.
    Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
    PLoS One; 2018; 13(1):e0191220. PubMed ID: 29346445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.
    Kuivaniemi H; Tromp G
    Gene; 2019 Jul; 707():151-171. PubMed ID: 31075413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome.
    Cooper TK; Zhong Q; Krawczyk M; Tae HJ; Müller GA; Schubert R; Myers LA; Dietz HC; Talan MI; Briest W
    Vet Pathol; 2010 Nov; 47(6):1028-39. PubMed ID: 20587693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ehlers-Danlos syndrome type IV: unusual congenital anomalies in a mother and son with a COL3A1 mutation and a normal collagen III protein profile.
    Kroes HY; Pals G; van Essen AJ
    Clin Genet; 2003 Mar; 63(3):224-7. PubMed ID: 12694234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency.
    Meienberg J; Rohrbach M; Neuenschwander S; Spanaus K; Giunta C; Alonso S; Arnold E; Henggeler C; Regenass S; Patrignani A; Azzarello-Burri S; Steiner B; Nygren AO; Carrel T; Steinmann B; Mátyás G
    Eur J Hum Genet; 2010 Dec; 18(12):1315-21. PubMed ID: 20648054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular Ehlers-Danlos Syndrome with a Novel Missense Mutation in COL3A1: A Man in His 50s with Aortic Dissection after Interventional Treatment for Hemothorax as the First Manifestation.
    Sakai K; Toda M; Kyoyama H; Nishimura H; Kojima A; Kuwabara Y; Kobayashi Y; Kikuchi S; Hirata Y; Moriyama G; Watanabe W; Akutsu K; Nakai M; Yamada T; Gemma A; Uematsu K
    Intern Med; 2019 Dec; 58(23):3441-3447. PubMed ID: 31391389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac valvular Ehlers-Danlos syndrome is a well-defined condition due to recessive null variants in COL1A2.
    Guarnieri V; Morlino S; Di Stolfo G; Mastroianno S; Mazza T; Castori M
    Am J Med Genet A; 2019 May; 179(5):846-851. PubMed ID: 30821104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ehlers-Danlos syndrome type IV in association with a (c.970G>A) mutation in the COL3A1 gene.
    Rebelo M; Ramos L; Lima J; Vieira JD; Tavares P; Teixeira L; Matos A; Costa JN
    Acta Med Port; 2011; 24(6):1079-86. PubMed ID: 22713205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular Ehlers-Danlos syndrome.
    Germain DP; Herrera-Guzman Y
    Ann Genet; 2004; 47(1):1-9. PubMed ID: 15127738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense mutation c.430C > T (p.Q105*) in the COL3A1 gene.
    Höpperger S; Spathopoulou A; Mayer-Suess L; Suarez-Cubero M; Sillaber K; Spreiz A; Kiechl S; Edenhofer F; Fellner L
    Stem Cell Res; 2024 Mar; 75():103321. PubMed ID: 38301384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring.
    Milewicz DM; Witz AM; Smith AC; Manchester DK; Waldstein G; Byers PH
    Am J Hum Genet; 1993 Jul; 53(1):62-70. PubMed ID: 8317500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.